BRPI0408097A - composição de insulina oral e processos para a produção e para o uso da mesma - Google Patents
composição de insulina oral e processos para a produção e para o uso da mesmaInfo
- Publication number
- BRPI0408097A BRPI0408097A BRPI0408097-1A BRPI0408097A BRPI0408097A BR PI0408097 A BRPI0408097 A BR PI0408097A BR PI0408097 A BRPI0408097 A BR PI0408097A BR PI0408097 A BRPI0408097 A BR PI0408097A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- processes
- production
- insulin
- mammal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 229940125395 oral insulin Drugs 0.000 title abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"COMPOSIçãO DE INSULINA ORAL E PROCESSOS PARA A PRODUçãO E PARA O USO DA MESMA". A presente invenção refere-se a um processo de diminuição da glicose no sangue em um mamífero que inclui a administração oral de uma quantidade terapeuticamente eficaz de micropartículas de dextrana cristalizadas e insulina ao mamífero para diminuir a glicose no sangue do mamífero. A composição pode ser uma composição de uma fase ou multifásica estruturada para a liberação controlada de insulina.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45124503P | 2003-03-04 | 2003-03-04 | |
| US46760103P | 2003-05-05 | 2003-05-05 | |
| US46901703P | 2003-05-09 | 2003-05-09 | |
| US49509703P | 2003-08-15 | 2003-08-15 | |
| IB2004009333 | 2004-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0408097A true BRPI0408097A (pt) | 2006-02-14 |
Family
ID=32831112
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408097-1A BRPI0408097A (pt) | 2003-03-04 | 2004-03-04 | composição de insulina oral e processos para a produção e para o uso da mesma |
| BRPI0408105-6A BRPI0408105A (pt) | 2003-03-04 | 2004-03-04 | sistema de distribuição para droga e terapia celular |
| BRPI0408100-5A BRPI0408100A (pt) | 2003-03-04 | 2004-03-04 | composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408105-6A BRPI0408105A (pt) | 2003-03-04 | 2004-03-04 | sistema de distribuição para droga e terapia celular |
| BRPI0408100-5A BRPI0408100A (pt) | 2003-03-04 | 2004-03-04 | composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US20040234615A1 (pt) |
| EP (3) | EP1603589A1 (pt) |
| JP (3) | JP2006519252A (pt) |
| KR (3) | KR20060015469A (pt) |
| AR (1) | AR046485A1 (pt) |
| AT (1) | ATE485051T1 (pt) |
| AU (3) | AU2004216909A1 (pt) |
| BR (3) | BRPI0408097A (pt) |
| CA (3) | CA2518143A1 (pt) |
| DE (1) | DE602004029630D1 (pt) |
| EA (3) | EA200501421A1 (pt) |
| EC (3) | ECSP056078A (pt) |
| MX (1) | MXPA05009493A (pt) |
| NO (3) | NO20054539L (pt) |
| PT (1) | PT1454630E (pt) |
| TW (1) | TW200529869A (pt) |
| WO (3) | WO2004078198A1 (pt) |
Families Citing this family (102)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166132A1 (en) * | 1998-08-26 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| WO2004078198A1 (en) * | 2003-03-04 | 2004-09-16 | The Technology Development Company Ltd. | Long acting injectable insulin composition and methods of making and using thereof |
| AU2004261353B2 (en) | 2003-08-05 | 2009-12-10 | Novo Nordisk A/S | Novel insulin derivatives |
| TW200603843A (en) * | 2004-04-20 | 2006-02-01 | Technology Dev Company Ltd | Tissue enhancement implant and method |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| FR2880272A1 (fr) * | 2005-01-04 | 2006-07-07 | Jean Marc Ruiz | Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication |
| WO2007025441A1 (en) * | 2005-08-29 | 2007-03-08 | Tuo Jin | Polysaccharide microparticles containing biological agents: there preparation and applications |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| EP1969004B1 (en) | 2005-12-28 | 2011-08-10 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| SE529040C2 (sv) * | 2006-01-18 | 2007-04-17 | Bows Pharmaceuticals Ag | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| EP2069062A2 (en) * | 2006-10-06 | 2009-06-17 | The President and Fellows of Harvard College | Chemically-directed electrostatic self-assembly of materials |
| JP5552046B2 (ja) | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー/エス | インスリン誘導体を含有する薬学的製剤 |
| EP2025334A1 (en) * | 2007-07-25 | 2009-02-18 | OctoPlus Sciences B.V. | Sustained release drug delivery system for repeated administration |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| FR2940802A1 (fr) * | 2008-10-10 | 2010-07-09 | Adocia | Complexe entre l'insuline humaine et un polymere amphiphile et utilisation de ce complexe pour la preparation d'une formulation d'insuline humaine rapide. |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| CN102202683A (zh) | 2008-10-30 | 2011-09-28 | 诺沃-诺迪斯克有限公司 | 用少于每日一次的注射频率注射胰岛素来治疗糖尿病 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| US9018190B2 (en) | 2009-03-27 | 2015-04-28 | Adocia | Functionalized oligosaccharides |
| FR2943538B1 (fr) * | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| PH12011502708B1 (en) | 2009-07-06 | 2017-11-10 | Sanofi Aventis Deutschland | Insulin preparations containing methionine |
| US9068182B2 (en) * | 2009-07-28 | 2015-06-30 | Corning Incorporated | Synthetic polysaccharide microcarriers for culturing cells |
| HUP0900482A2 (en) | 2009-08-03 | 2011-03-28 | Cera Med Kft | Pharmaceutical formulation for oral administration |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| JP5832439B2 (ja) | 2009-11-13 | 2015-12-16 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物 |
| SG10201500871TA (en) | 2009-11-13 | 2015-04-29 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
| AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| CN103179978A (zh) | 2010-08-30 | 2013-06-26 | 赛诺菲-安万特德国有限公司 | Ave0010用于制造供治疗2型糖尿病用的药物的用途 |
| DK2632478T3 (da) | 2010-10-27 | 2019-10-07 | Novo Nordisk As | Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| EP2739303B1 (en) * | 2011-08-07 | 2020-04-01 | Transgene Biotek Ltd. | A novel method for peroral delivery of insulin and its analogues for therapeutic usage |
| JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| US9157939B2 (en) * | 2012-08-09 | 2015-10-13 | Infineon Technologies Ag | System and device for determining electric voltages |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| EP2919804B1 (fr) | 2012-11-13 | 2018-01-31 | Adocia | Formulation à action rapide d'insuline comprenant un composé anionique substitué |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| EP3517122A1 (en) | 2013-04-03 | 2019-07-31 | Sanofi | Treatment of diabetes mellitus by long-acting formulations of insulins |
| EP2991672A1 (en) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
| JP6200698B2 (ja) * | 2013-06-18 | 2017-09-20 | ニュートリー株式会社 | 嚥下造影検査食 |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| FR3020947B1 (fr) | 2014-05-14 | 2018-08-31 | Adocia | Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| RU2014120626A (ru) * | 2014-05-22 | 2015-11-27 | Владимир Андреевич Сабецкий | Инсулинсодержащий препарат пролонгированного действия |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| CN105617362B (zh) * | 2014-10-27 | 2021-05-11 | 中国医学科学院药物研究所 | 一种新型的胰岛素-磷脂-壳聚糖自组装微粒载体及其制剂 |
| CN107206058A (zh) | 2014-12-12 | 2017-09-26 | 赛诺菲-安万特德国有限公司 | 甘精胰岛素/利西拉来固定比率配制剂 |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
| FR3043557B1 (fr) | 2015-11-16 | 2019-05-31 | Adocia | Composition a action rapide d'insuline comprenant un citrate substitue |
| US10660941B2 (en) | 2016-02-19 | 2020-05-26 | Indian Institute Of Technology, Bombay | Orally administrable pharmaceutical preparation containing protein |
| RU2647466C1 (ru) * | 2016-12-01 | 2018-03-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) | Способ получения нативного белка пролонгирующего действия в составе полимерных наносфер и резорбируемых микросфер для доставки |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| CN114096269B (zh) | 2019-07-12 | 2024-06-11 | 诺和诺德股份有限公司 | 高浓度胰岛素制剂 |
| KR20200056360A (ko) | 2020-04-29 | 2020-05-22 | 김용원 | 자전거바퀴(회전자)와 바퀴덮개(고정자)에 설치하는 발전기 |
| KR20200056359A (ko) | 2020-04-29 | 2020-05-22 | 김용원 | 퀵보드 등 승용기구바퀴(회전자)에 설치되는 바퀴덮개(고정자)에 설치하는 발전기 |
| KR20200056361A (ko) | 2020-05-04 | 2020-05-22 | 김용원 | 발판보드에 설치하는 발전기 |
| KR20200060307A (ko) | 2020-05-06 | 2020-05-29 | 김용원 | 자전거와 리어 캐리어에 설치하는 발전장치들 |
| KR20200060308A (ko) | 2020-05-07 | 2020-05-29 | 김용원 | 수상보드에 설치하는 발전기 |
| KR20200060309A (ko) | 2020-05-08 | 2020-05-29 | 김용원 | 헬스차량에 설치하는 발전기 |
| KR20200061324A (ko) | 2020-05-11 | 2020-06-02 | 김용원 | 보트에 설치하는 발전기 |
| KR20200062092A (ko) | 2020-05-11 | 2020-06-03 | 김용원 | 수차와 공기 컴프레서를 이용한 공기 터빈구조 발전기와 바퀴구조 발전기를 합한 발전기 |
| KR20200068614A (ko) | 2020-05-26 | 2020-06-15 | 김용원 | 펠티어소자를 이용한 공기, 물 컨디션너 조절장치 내에 설치한 발전기 |
| KR20200083393A (ko) | 2020-06-16 | 2020-07-08 | 김용원 | "공기 터빈구조 발전기"와 "바퀴구조를 합한 발전기"를 "발열소자를 이용한 발전기"와 적용 양방향 모터(양방향 프로펠러)를 양방향공기추진기(Propullor)와 결합 장착한 드론 |
| KR20200088241A (ko) | 2020-06-30 | 2020-07-22 | 김용원 | 역방향 모터(양방향 프로펠러)의 추진에 맞는 관성을 이기는 팬이 없는 양방향공기추진기(Propullor)를 장착한 드론 |
| KR20200108392A (ko) | 2020-08-31 | 2020-09-18 | 김용원 | 전동 오토바이 모터의 정격에 맞는 오토바이바퀴에 회전자와 물받이 고정자 발전기를 설치한 오토바이에 모터가 장착된 항공기 공기추진기(Propulsor)와 장착한 드론의 프로퓰러(Propullor)를 장착하는 제조기술) |
| EP4274663A4 (en) * | 2021-01-07 | 2024-10-16 | Ramot at Tel-Aviv University Ltd. | METHODS AND COMPOSITIONS FOR THE SYNTHESIS OF MELANIN |
| KR20210018367A (ko) | 2021-01-26 | 2021-02-17 | 김용원 | 전동 오토바이에 설치한 모터가 장착된 항공기 공기추진기와 장착한 프로퓰러(Propullor)로 구성한 오토에어크라프트(Autoaircraft) |
| KR20210029730A (ko) | 2021-02-22 | 2021-03-16 | 김용원 | 산사태에 대비, 대응하는 에어 레이어들 블록들이 형성된 거대장비들(에어 레이어들 블록들) |
| KR20210040852A (ko) | 2021-03-24 | 2021-04-14 | 김용원 | 전동에어버스 |
| KR20210043513A (ko) | 2021-03-26 | 2021-04-21 | 김용원 | 전동에어버스에 설치하는 연기(분연), 재 포집장치 |
| KR20210045369A (ko) | 2021-03-31 | 2021-04-26 | 김용원 | 전기 에어 카 |
| KR20210049046A (ko) | 2021-04-13 | 2021-05-04 | 김용원 | 전기에어버스를 강풍, 태풍에 구조하는 보조날개와 보조출입문 장치 |
| KR20210055643A (ko) | 2021-04-27 | 2021-05-17 | 김용원 | 모터가 장착된 회전축에 다량의 회전자바퀴와 다량의 고정자바퀴발전기를 설치한 전동보드 |
| KR20210072739A (ko) | 2021-05-27 | 2021-06-17 | 김용원 | 의료용 전동보드 |
| KR20210080293A (ko) | 2021-06-11 | 2021-06-30 | 김용원 | 바퀴 사이 발전기 케이스 |
| CN115702880B (zh) * | 2021-08-12 | 2023-11-03 | 山东新时代药业有限公司 | 一种重组甘精胰岛素注射液及其制备工艺 |
| KR20220016234A (ko) | 2022-01-14 | 2022-02-08 | 김용원 | 공기추진기(공기펌프와 공기터빈)를 장착한 3륜 자전거 |
| KR20220038026A (ko) | 2022-02-24 | 2022-03-25 | 김용원 | 4합 공기터빈 : 공기터빈 축에 1. 인너 팬들의 인너 실린더와 2. 아웃터 팬들의 아웃터 실린더와 3. 양쪽 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들에 덕트팬들과 덕트흡입구와 4 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들의 3. 덕트팬들에 블레이드와 블레이드 외부 형틀 |
| KR20220056159A (ko) | 2022-04-04 | 2022-05-04 | 김용원 | 물탱크 내의 스팀집 슈퍼히터에 전력공급한 스팀공급으로 스팀터빈을 구동하는 것과 슈퍼히터로 스팀을 공급하는 스팀청소기에 발전기들을 설치하는 것과 공기터빈의 흡입구들의 공기필터들 설치와 펠티에소자를 이용한 냉온 공기배출과 얼음제조기 시스템 |
| KR20220056835A (ko) | 2022-04-18 | 2022-05-06 | 김용원 | 공기추진기(공기펌프와 여러 공기터빈들)들을 장착한 수상 자전거 |
| KR20220076421A (ko) | 2022-05-11 | 2022-06-08 | 김용원 | 공기추진기(공기펌프와 공기터빈들)들을 장착한 페달자전차 |
| KR20220080053A (ko) | 2022-05-27 | 2022-06-14 | 김용원 | 다중 에어 레이어 튜브보트 |
| WO2024167359A1 (ko) * | 2023-02-08 | 2024-08-15 | 주식회사 인벤테라 | 정맥오염 없는 림프관 조영제 |
| KR20250070006A (ko) | 2025-04-23 | 2025-05-20 | 김용원 | 수륙양용 전동보드 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8204244L (sv) * | 1982-07-09 | 1984-01-10 | Ulf Schroder | Kristalliserad kolhydratsmatris for biologiskt aktiva substanser |
| US4713249A (en) * | 1981-11-12 | 1987-12-15 | Schroeder Ulf | Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
| US4963526A (en) * | 1984-05-09 | 1990-10-16 | Synthetic Blood Corporation | Oral insulin and a method of making the same |
| EP0247077A1 (en) | 1985-10-22 | 1987-12-02 | ROBINSON, Eric | Process for cell immobilisation |
| PH30995A (en) * | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
| USRE37950E1 (en) * | 1990-04-24 | 2002-12-31 | Atrix Laboratories | Biogradable in-situ forming implants and methods of producing the same |
| US5618531A (en) | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
| US5840290A (en) * | 1996-05-30 | 1998-11-24 | University Of Florida Research Foundation | Injectable bio-active glass in a dextran suspension |
| US5783556A (en) * | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
| EP0842657A1 (en) * | 1996-11-19 | 1998-05-20 | OctoPlus B.V. | Microspheres for controlled release and processes to prepare these microspheres |
| US6395302B1 (en) | 1996-11-19 | 2002-05-28 | Octoplus B.V. | Method for the preparation of microspheres which contain colloidal systems |
| EP1371364B1 (en) * | 1996-11-19 | 2006-04-12 | OctoPlus B.V. | Proces for the preparation of a controlled release system |
| FR2764514B1 (fr) * | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique |
| JP2001509419A (ja) * | 1997-07-10 | 2001-07-24 | ユーエスバイオマテリアルズ コーポレイション | 成形可能な生物活性組成物 |
| US6194006B1 (en) * | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
| US20020054914A1 (en) | 1999-02-03 | 2002-05-09 | Tulin Morcol | Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein |
| JP4865947B2 (ja) * | 1999-02-19 | 2012-02-01 | ウニフェルシテイト ユトレヒト | ステレオコンプレックスヒドロゲル |
| FR2794649B1 (fr) * | 1999-06-11 | 2003-04-11 | Solutions | Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications |
| WO2001023563A2 (en) * | 1999-09-27 | 2001-04-05 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| EP1184032A1 (en) * | 2000-08-31 | 2002-03-06 | OctoPlus B.V. | Dextran hydrogels |
| FR2814951B1 (fr) | 2000-10-06 | 2003-01-17 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation |
| WO2002039985A1 (en) | 2000-11-16 | 2002-05-23 | Jagotec Ag | Parenterally administrable microparticles |
| WO2002067995A1 (en) * | 2001-02-26 | 2002-09-06 | Council Of Scientific And Industrial Research | Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines |
| EP1270012A1 (en) * | 2001-06-21 | 2003-01-02 | Pfizer Products Inc. | Use of pulmonary administration of insulin for treatment of diabetes |
| WO2004078198A1 (en) * | 2003-03-04 | 2004-09-16 | The Technology Development Company Ltd. | Long acting injectable insulin composition and methods of making and using thereof |
| SE529040C2 (sv) * | 2006-01-18 | 2007-04-17 | Bows Pharmaceuticals Ag | Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin |
-
2004
- 2004-03-04 WO PCT/IB2004/000984 patent/WO2004078198A1/en not_active Ceased
- 2004-03-04 EP EP04717199A patent/EP1603589A1/en not_active Withdrawn
- 2004-03-04 AR ARP040100691A patent/AR046485A1/es unknown
- 2004-03-04 JP JP2006506415A patent/JP2006519252A/ja active Pending
- 2004-03-04 KR KR1020057016506A patent/KR20060015469A/ko not_active Withdrawn
- 2004-03-04 AU AU2004216909A patent/AU2004216909A1/en not_active Abandoned
- 2004-03-04 KR KR1020057016543A patent/KR20060015472A/ko not_active Withdrawn
- 2004-03-04 AT AT04251251T patent/ATE485051T1/de not_active IP Right Cessation
- 2004-03-04 KR KR1020057016544A patent/KR20060014027A/ko not_active Withdrawn
- 2004-03-04 JP JP2006506422A patent/JP2006519253A/ja active Pending
- 2004-03-04 PT PT04251251T patent/PT1454630E/pt unknown
- 2004-03-04 AU AU2004216911A patent/AU2004216911A1/en not_active Abandoned
- 2004-03-04 BR BRPI0408097-1A patent/BRPI0408097A/pt not_active IP Right Cessation
- 2004-03-04 EP EP04251253A patent/EP1454631A1/en not_active Withdrawn
- 2004-03-04 EA EA200501421A patent/EA200501421A1/ru unknown
- 2004-03-04 DE DE602004029630T patent/DE602004029630D1/de not_active Expired - Lifetime
- 2004-03-04 CA CA002518143A patent/CA2518143A1/en not_active Abandoned
- 2004-03-04 EA EA200501420A patent/EA200501420A1/ru unknown
- 2004-03-04 MX MXPA05009493A patent/MXPA05009493A/es active IP Right Grant
- 2004-03-04 WO PCT/IB2004/000961 patent/WO2004078197A1/en not_active Ceased
- 2004-03-04 CA CA002518136A patent/CA2518136A1/en not_active Abandoned
- 2004-03-04 AU AU2004216908A patent/AU2004216908A1/en not_active Abandoned
- 2004-03-04 US US10/792,376 patent/US20040234615A1/en not_active Abandoned
- 2004-03-04 EA EA200501422A patent/EA200501422A1/ru unknown
- 2004-03-04 US US10/792,383 patent/US7544656B2/en not_active Expired - Fee Related
- 2004-03-04 BR BRPI0408105-6A patent/BRPI0408105A/pt not_active IP Right Cessation
- 2004-03-04 JP JP2006506401A patent/JP2006519840A/ja active Pending
- 2004-03-04 EP EP04251251A patent/EP1454630B1/en not_active Expired - Lifetime
- 2004-03-04 CA CA002518148A patent/CA2518148A1/en not_active Abandoned
- 2004-03-04 US US10/548,213 patent/US20110097385A1/en not_active Abandoned
- 2004-03-04 WO PCT/IB2004/000933 patent/WO2004078196A1/en not_active Ceased
- 2004-03-04 BR BRPI0408100-5A patent/BRPI0408100A/pt not_active IP Right Cessation
- 2004-03-04 TW TW093105776A patent/TW200529869A/zh unknown
-
2005
- 2005-10-03 NO NO20054539A patent/NO20054539L/no unknown
- 2005-10-03 NO NO20054534A patent/NO20054534L/no not_active Application Discontinuation
- 2005-10-03 NO NO20054533A patent/NO20054533L/no not_active Application Discontinuation
- 2005-10-04 EC EC2005006078A patent/ECSP056078A/es unknown
- 2005-10-04 EC EC2005006077A patent/ECSP056077A/es unknown
- 2005-10-04 EC EC2005006076A patent/ECSP056076A/es unknown
-
2010
- 2010-03-08 US US12/719,633 patent/US20100166855A1/en not_active Abandoned
- 2010-03-08 US US12/719,636 patent/US20100167985A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056077A (es) | Composición de insulina oral y métodos de fabricación y uso de estos | |
| BRPI0312398B8 (pt) | derivado de 1,3-difenilprop-2-en-1-ona substituído, processo de preparação de compostos, composição farmacêutica e utilização de pelo menos um derivado de 1,3-difenilprop-2-en-1-ona substituído | |
| BR0107147A (pt) | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações | |
| AR047779A1 (es) | Composiciones y metodos para tratar diabetes | |
| BR0113710A (pt) | Compostos, processo para a preparação e utilização dos mesmos, composição farmacêutica, processo para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, insuficiência renal, distúrbios alimentares e obesidade | |
| PT1326613E (pt) | Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos | |
| BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
| BRPI0912842A8 (pt) | composição farmacêutica, métodos para prevenir ou tratar o rubor induzido por niacina em um indivíduo, para reduzir pelo menos um sintoma de rubor relacionado com a terapia com niacina em um indivíduo, para diminuir os efeitos colaterais relacionados com a protaglandina em um indivíduo, para diminuir uma taxa de descontinuação do tratamento com niacina por um indivíduo, para aumentar a submissão do paciente ao tratamento com niacina, para tratar aterosclerose em um paciente, para tratar uma doença relacionada com um perfil de hdl baixo em um paciente, formulação do ácido nicotínico de dispensação modificada, uso da composição farmacêutica, e, microcápsula de aspirina | |
| BR0315720A (pt) | Composto, método para a profilaxia ou tratamento de uma condição clìnica em um mamìmefero, formulação farmacêutica, combinação, uso de um composto, processo para a preparação de um composto, e, intermediário | |
| BRPI0719486A2 (pt) | "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente" | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| BR9909277A (pt) | Compostos com atividade em receptores muscarìnicos | |
| BRPI0011867B8 (pt) | preparação farmacêutica de levodopa/carbidopa/entacapona e processo para preparação da mesma | |
| WO2008061226A3 (en) | Sustained-release formulations of topiramate | |
| BR9408378A (pt) | Composto sal farmaceuticamente aceitável composição farmacêutica e processos para o tratamento de um paciente que sofreu um derrame e que sofre de uma condição de perda progressiva de função de sistema nervoso central e para melhorar os efeitos colaterais causados em um paciente por tratamento antineoplástico de doença que produz danos oxidativos | |
| BR0307540A (pt) | Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo | |
| BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
| BRPI0414565A (pt) | composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato | |
| BR0014142A (pt) | Composição de vacina e método de empregar a mesma | |
| PE20031044A1 (es) | Derivados de fenilimidazolidina y proceso de preparacion | |
| BRPI0507657A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
| BR0315462A (pt) | Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação | |
| BRPI0406634A (pt) | Uso de um anagrelìdeo, anagrelìdeo na forma de base, ou um sal farmaceuticamente aceitável do anagrelìdeo, composição farmacêutica não-oral, e dispositivo médido para administração transdérmica | |
| BRPI0414518A (pt) | composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 8A ANUIDADES. |
|
| B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A E 11A ANUIDADES. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |